Clinical application of chest CT image screening combined with nanopore targeted sequencing in improving the diagnosis rate of pulmonary tuberculosis patients
Open Access
- 23 July 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1826208
Abstract
Background: How to increase the diagnosis rate of pulmonary tuberculosis (PTB) has always been a major challenge in medicine. Compared with conventional microbiological tests (CMTs), nanopore targeted sequencing (NTS) is undoubtedly a faster and more effective diagnostic method. This study explores the feasibility of combining chest CT imaging screening with NTS to improve PTB diagnosis. Method: This retrospective observational study was conducted from March 2023 to December 2024, enrolling 380 patients from a single center who underwent bronchoalveolar lavage fluid (BALF) analysis and NTS testing. We compared the diagnostic accuracy of radiologists with varying experience levels to determine the most suitable preliminary screening protocol for PTB. Additionally, we compared NTS results with CMTs (including mycobacterial culture, acid-fast bacilli smear and Xpert MTB/RIF) to evaluate differences in diagnostic performance between NTS and CMTs. Results: We conducted a horizontal comparison of PTB diagnostic accuracy among three radiologists with different levels of experience. The most experienced radiologist had the lowest missed diagnosis rate. When combining cases suspected by all three radiologists (202 cases), the missed diagnosis rate dropped to as low as 9.09% (27.27% [95% CI: 16.77–40.70%] vs. 30.91% [95% CI: 19.73–44.51%] vs. 16.36% [95% CI: 8.38–29.82%] vs. 9.09% [95% CI: 3.80–19.84%], p = 0.019). Furthermore, we analyzed the diagnostic performance of NTS and CMTs in PTB patients and found that NTS had significantly higher sensitivity than Xpert MTB/RIF, mycobacterial culture, and acid-fast bacilli smear (89.09% [95% CI: 78.17–95.02%] vs. 78.18% [95% CI: 65.44–87.12%] vs. 23.64% [95% CI: 13.99–36.99%] vs. 16.36% [95% CI: 8.38–28.82%], p < 0.001). ROC analysis demonstrated that incorporating NTS into the testing of suspected PTB specimens significantly improved diagnostic capability (AUC = 0.990, 95% CI: 0.968–1.000). Conclusion: Radiologists’ experience in PTB imaging diagnosis can reduce missed diagnoses. Additionally, combining NTS with CMTs helps improve early diagnosis in suspected PTB patients. The combined use of NTS and Xpert MTB/RIF yielded the highest diagnostic accuracy (AUC 0.990).Keywords
This publication has 37 references indexed in Scilit:
- Evaluation of the deeplex Myc-TB-targeted next-generation sequencing assay for mycobacterial identification and drug resistance detectionJournal of Clinical Microbiology, 2026
- Diagnostic accuracy of nanopore sequencing for detecting Mycobacterium tuberculosis and drug-resistant strains: a systematic review and meta-analysisScientific Reports, 2025
- The 2023 UN high-level meeting on tuberculosis: renewing hope, momentum, and commitment to end tuberculosisThe Lancet Respiratory Medicine, 2023
- The application of nanopore targeted sequencing for pathogen diagnosis in bronchoalveolar lavage fluid of patients with pneumonia: a prospective multicenter studyInfectious Diseases, 2023
- Evaluation of Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation: a genomic analysisThe Lancet Microbe, 2022
- Portable sequencing of Mycobacterium tuberculosis for clinical and epidemiological applicationsBriefings in Bioinformatics, 2022
- Nanopore Sequencing and Its Clinical Applications2020
- Nanopore sequencing and assembly of a human genome with ultra-long readsNature Biotechnology, 2018
- Radiological patterns of childhood thoracic tuberculosis in a developed country: a single institution’s experience on 217/255 casesLa radiologia medica, 2016
- Relevance of Commercial Amplification Methods for Direct Detection of Mycobacterium tuberculosis Complex in Clinical SamplesJournal of Clinical Microbiology, 2003